Related Experiment Video
Updated: May 11, 2026
10:39
Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
Cytokine targets in airway inflammation
Martijn J Schuijs1, Monique A Willart, Hamida Hammad
1Department for Molecular Biomedical Research, VIB, Ghent, Belgium.
Current Opinion in Pharmacology
|May 7, 2013
Summary
Asthma involves airway inflammation and obstruction, driven by immune cells and cytokines. Understanding cell communication is key to developing new therapies for this chronic respiratory disease.
Area of Science:
- Immunology
- Respiratory Medicine
- Cell Biology
Background:
- Asthma is a chronic airway inflammatory disease characterized by hyper-reactivity and obstruction.
- Key players include adaptive immune cells (Th2, Th17 lymphocytes) and innate immune cells (mast cells, eosinophils, dendritic cells, innate lymphoid cells).
- Epithelial cells are increasingly recognized for their role in sensing pathogens and activating immune responses.
Purpose of the Study:
- To review the critical role of cytokines in asthma pathogenesis.
- To explore the crosstalk between structural, innate, and adaptive immune cells mediated by cytokines.
- To provide insights for developing novel therapeutic strategies for asthma.
Main Methods:
- This is a review article, synthesizing existing research on asthma pathogenesis.
- Focuses on the function of various cytokines, including emerging Th2 cytokines.
- Examines the interactions between epithelial cells, dendritic cells, and innate lymphoid cells.
Main Results:
- Cytokines like IL-4, IL-5, IL-13, and IL-17 are central to asthma's inflammatory processes.
- Emerging cytokines (TSLP, GM-CSF, IL-1, IL-33, IL-25) facilitate communication between epithelial cells, dendritic cells, and innate lymphoid cells.
- Cytokine-mediated crosstalk is crucial for the development and persistence of asthma.
Conclusions:
- Understanding the complex interplay of cells and cytokines is essential for unraveling asthma mechanisms.
- This knowledge can guide the development of targeted therapies to prevent exacerbations and modify disease progression.
- Targeting cytokine-mediated pathways offers a promising framework for future asthma treatments.
Related Concept Videos
01:17Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include: